NO300843B1 - Aryliden-l-azacykloalkaner og arylalkyl-l-azacykloalkaner, salter av disse, og legemidler som inneholder disse forbindelser - Google Patents

Info

Publication number

NO300843B1

NO300843B1 NO933790A NO933790A NO300843B1 NO 300843 B1 NO300843 B1 NO 300843B1 NO 933790 A NO933790 A NO 933790A NO 933790 A NO933790 A NO 933790A NO 300843 B1 NO300843 B1 NO 300843B1

Authority

NO

Norway

Prior art keywords

group

piperidine

benzylidene

oxazolin

hydrogen atom

Prior art date

1992-10-22

Links

• Espacenet
• Global Dossier
• Discuss

• 150000003839 salts Chemical class 0.000 title claims abstract description 18
• 150000001875 compounds Chemical class 0.000 title claims description 112
• 239000003814 drug Substances 0.000 title claims description 6
• 229940079593 drug Drugs 0.000 title claims description 5
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 71
• 235000012000 cholesterol Nutrition 0.000 claims abstract description 34
• 230000015572 biosynthetic process Effects 0.000 claims abstract description 32
• 230000002401 inhibitory effect Effects 0.000 claims abstract description 8
• 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 62
• 125000004432 carbon atom Chemical group C* 0.000 claims description 49
• 125000000217 alkyl group Chemical group 0.000 claims description 48
• 125000005843 halogen group Chemical group 0.000 claims description 46
• 238000011282 treatment Methods 0.000 claims description 27
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 26
• -1 methoxy, cyano, nitro, methylsulfonyl Chemical group 0.000 claims description 20
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 19
• 208000001130 gallstones Diseases 0.000 claims description 15
• JQNWPWUJMRAASQ-UHFFFAOYSA-N (4-chlorophenyl)-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)N(CC1)CCC1=CC1=CC=C(C=2OCCN=2)C=C1 JQNWPWUJMRAASQ-UHFFFAOYSA-N 0.000 claims description 14
• 229910052731 fluorine Inorganic materials 0.000 claims description 14
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 14
• 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 14
• 229910052739 hydrogen Inorganic materials 0.000 claims description 13
• 239000001257 hydrogen Substances 0.000 claims description 13
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 12
• 229910052801 chlorine Inorganic materials 0.000 claims description 12
• 238000002360 preparation method Methods 0.000 claims description 12
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 12
• 238000004519 manufacturing process Methods 0.000 claims description 11
• 239000011203 carbon fibre reinforced carbon Substances 0.000 claims description 10
• 125000001153 fluoro group Chemical group F* 0.000 claims description 10
• WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 9
• 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 9
• 201000010099 disease Diseases 0.000 claims description 9
• MIEDZIDGNDSSOM-UHFFFAOYSA-N (4-chlorophenyl)-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methyl]piperidin-1-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)N1CCC(CC=2C=CC(=CC=2)C=2OCCN=2)CC1 MIEDZIDGNDSSOM-UHFFFAOYSA-N 0.000 claims description 8
• KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 8
• PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 8
• KLNRNRKDOKSJSW-UHFFFAOYSA-N [4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]-[4-(trifluoromethyl)phenyl]methanone Chemical compound C1=CC(C(F)(F)F)=CC=C1C(=O)N(CC1)CCC1=CC1=CC=C(C=2OCCN=2)C=C1 KLNRNRKDOKSJSW-UHFFFAOYSA-N 0.000 claims description 8
• 125000002947 alkylene group Chemical group 0.000 claims description 8
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 8
• 239000000460 chlorine Substances 0.000 claims description 8
• 125000004093 cyano group Chemical group *C#N 0.000 claims description 8
• 239000011737 fluorine Substances 0.000 claims description 8
• 125000004430 oxygen atom Chemical group O* 0.000 claims description 8
• 230000002265 prevention Effects 0.000 claims description 8
• 125000001544 thienyl group Chemical group 0.000 claims description 8
• NGIXKIZJFNNRII-UHFFFAOYSA-N (5-chlorothiophen-2-yl)-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]methanone Chemical compound S1C(Cl)=CC=C1C(=O)N(CC1)CCC1=CC1=CC=C(C=2OCCN=2)C=C1 NGIXKIZJFNNRII-UHFFFAOYSA-N 0.000 claims description 7
• 208000031888 Mycoses Diseases 0.000 claims description 7
• RSWURALHCSSUTE-UHFFFAOYSA-N [4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]-(4-fluorophenyl)methanone Chemical compound C1=CC(F)=CC=C1C(=O)N(CC1)CCC1=CC1=CC=C(C=2OCCN=2)C=C1 RSWURALHCSSUTE-UHFFFAOYSA-N 0.000 claims description 7
• 125000003545 alkoxy group Chemical group 0.000 claims description 7
• 239000000126 substance Substances 0.000 claims description 7
• ZZPNBERPQGKKRC-UHFFFAOYSA-N (4-chloro-3-methylphenyl)-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]methanone Chemical compound C1=C(Cl)C(C)=CC(C(=O)N2CCC(CC2)=CC=2C=CC(=CC=2)C=2OCCN=2)=C1 ZZPNBERPQGKKRC-UHFFFAOYSA-N 0.000 claims description 6
• MIDPJHYJPFLNRP-UHFFFAOYSA-N (4-chlorophenyl)-[3-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]pyrrolidin-1-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)N(CC1)CC1=CC1=CC=C(C=2OCCN=2)C=C1 MIDPJHYJPFLNRP-UHFFFAOYSA-N 0.000 claims description 6
• BCSGBGSVOMSSAM-UHFFFAOYSA-N (4-chlorophenyl)-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)-2-fluorophenyl]methylidene]piperidin-1-yl]methanone Chemical compound FC1=CC(C=2OCCN=2)=CC=C1C=C(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 BCSGBGSVOMSSAM-UHFFFAOYSA-N 0.000 claims description 6
• HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 6
• VJIRPVAYIRYZQL-UHFFFAOYSA-N [4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methyl]piperidin-1-yl]-[4-(trifluoromethyl)phenyl]methanone Chemical compound C1=CC(C(F)(F)F)=CC=C1C(=O)N1CCC(CC=2C=CC(=CC=2)C=2OCCN=2)CC1 VJIRPVAYIRYZQL-UHFFFAOYSA-N 0.000 claims description 6
• 125000004450 alkenylene group Chemical group 0.000 claims description 6
• 125000004414 alkyl thio group Chemical group 0.000 claims description 6
• 125000000753 cycloalkyl group Chemical group 0.000 claims description 6
• CENDSAPOSUTQHX-UHFFFAOYSA-N cyclohexyl-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]methanone Chemical compound C1CC(=CC=2C=CC(=CC=2)C=2OCCN=2)CCN1C(=O)C1CCCCC1 CENDSAPOSUTQHX-UHFFFAOYSA-N 0.000 claims description 6
• 235000013601 eggs Nutrition 0.000 claims description 6
• 125000004076 pyridyl group Chemical group 0.000 claims description 6
• GGVUEPVVIOLBRU-UHFFFAOYSA-N (4-chlorophenyl)-[4-[[4-(oxazinan-2-yl)phenyl]methylidene]piperidin-1-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)N(CC1)CCC1=CC1=CC=C(N2OCCCC2)C=C1 GGVUEPVVIOLBRU-UHFFFAOYSA-N 0.000 claims description 5
• 208000031226 Hyperlipidaemia Diseases 0.000 claims description 5
• 230000004663 cell proliferation Effects 0.000 claims description 5
• YDPFQUVMHKAVQG-UHFFFAOYSA-N (4-chlorophenyl)-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)-3-methylphenyl]methylidene]piperidin-1-yl]methanone Chemical compound C=1C=C(C=2OCCN=2)C(C)=CC=1C=C(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 YDPFQUVMHKAVQG-UHFFFAOYSA-N 0.000 claims description 4
• MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 4
• 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 4
• 125000004419 alkynylene group Chemical group 0.000 claims description 4
• 125000001309 chloro group Chemical group Cl* 0.000 claims description 4
• 125000004663 dialkyl amino group Chemical group 0.000 claims description 4
• 125000001624 naphthyl group Chemical group 0.000 claims description 4
• 229910052760 oxygen Inorganic materials 0.000 claims description 4
• 239000001301 oxygen Substances 0.000 claims description 4
• 229910052717 sulfur Inorganic materials 0.000 claims description 4
• 125000004434 sulfur atom Chemical group 0.000 claims description 4
• 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 claims description 4
• 125000005191 hydroxyalkylamino group Chemical group 0.000 claims description 3
• 150000007522 mineralic acids Chemical class 0.000 claims description 3
• 150000007524 organic acids Chemical class 0.000 claims description 3
• 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 claims description 2
• 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 claims description 2
• 125000006524 alkoxy alkyl amino group Chemical group 0.000 claims description 2
• 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 2
• 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 2
• 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
• 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
• 235000005985 organic acids Nutrition 0.000 claims description 2
• 239000003085 diluting agent Substances 0.000 claims 1
• 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
• 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims 1
• 239000000203 mixture Substances 0.000 abstract description 43
• 238000002844 melting Methods 0.000 description 105
• 230000008018 melting Effects 0.000 description 105
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 67
• NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 54
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 48
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 44
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 43
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 39
• MMDGEHBTHZXZLX-UHFFFAOYSA-N 2-[4-(piperidin-4-ylidenemethyl)phenyl]-4,5-dihydro-1,3-oxazole Chemical compound O1CCN=C1C(C=C1)=CC=C1C=C1CCNCC1 MMDGEHBTHZXZLX-UHFFFAOYSA-N 0.000 description 31
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 31
• 238000006243 chemical reaction Methods 0.000 description 28
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
• HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 22
• ROLMZTIHUMKEAI-UHFFFAOYSA-N 4,5-difluoro-2-hydroxybenzonitrile Chemical compound OC1=CC(F)=C(F)C=C1C#N ROLMZTIHUMKEAI-UHFFFAOYSA-N 0.000 description 22
• 239000003112 inhibitor Substances 0.000 description 22
• 239000000243 solution Substances 0.000 description 22
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 22
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
• 238000000034 method Methods 0.000 description 17
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 16
• 239000000741 silica gel Substances 0.000 description 16
• 229910002027 silica gel Inorganic materials 0.000 description 16
• IQQZQHHFNQQONM-UHFFFAOYSA-N 2-[4-(piperidin-4-ylmethyl)phenyl]-4,5-dihydro-1,3-oxazole Chemical compound C=1C=C(C=2OCCN=2)C=CC=1CC1CCNCC1 IQQZQHHFNQQONM-UHFFFAOYSA-N 0.000 description 14
• YSHOWEKUVWPFNR-UHFFFAOYSA-N Burgess reagent Substances CC[N+](CC)(CC)S(=O)(=O)N=C([O-])OC YSHOWEKUVWPFNR-UHFFFAOYSA-N 0.000 description 14
• MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 14
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 14
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
• 238000003756 stirring Methods 0.000 description 12
• 102100032011 Lanosterol synthase Human genes 0.000 description 11
• 108010059597 Lanosterol synthase Proteins 0.000 description 11
• 239000013543 active substance Substances 0.000 description 11
• 239000012230 colorless oil Substances 0.000 description 11
• AOBXGZHWDJSPRW-UHFFFAOYSA-N 2-[4-(diethoxyphosphorylmethyl)phenyl]-4,5-dihydro-1,3-oxazole Chemical compound C1=CC(CP(=O)(OCC)OCC)=CC=C1C1=NCCO1 AOBXGZHWDJSPRW-UHFFFAOYSA-N 0.000 description 10
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 10
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
• PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 description 10
• SXWRTZOXMUOJER-UHFFFAOYSA-N hydron;piperidin-4-one;chloride;hydrate Chemical compound O.Cl.O=C1CCNCC1 SXWRTZOXMUOJER-UHFFFAOYSA-N 0.000 description 10
• PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 10
• QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 description 10
• 239000002904 solvent Substances 0.000 description 10
• 238000012360 testing method Methods 0.000 description 10
• VVTSPGAEYDBBSQ-UHFFFAOYSA-N 1-(4-chlorobenzoyl)piperidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(=O)N1CCC(=O)CC1 VVTSPGAEYDBBSQ-UHFFFAOYSA-N 0.000 description 9
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
• 208000035475 disorder Diseases 0.000 description 9
• 238000009472 formulation Methods 0.000 description 9
• 230000005764 inhibitory process Effects 0.000 description 9
• 239000003208 petroleum Substances 0.000 description 9
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
• KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 8
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
• PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 8
• 210000004027 cell Anatomy 0.000 description 8
• ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 8
• 229960004844 lovastatin Drugs 0.000 description 8
• 239000000047 product Substances 0.000 description 8
• 239000011347 resin Substances 0.000 description 8
• 229920005989 resin Polymers 0.000 description 8
• 238000004440 column chromatography Methods 0.000 description 7
• 238000001816 cooling Methods 0.000 description 7
• 239000013078 crystal Substances 0.000 description 7
• 238000005984 hydrogenation reaction Methods 0.000 description 7
• 210000003491 skin Anatomy 0.000 description 7
• 239000007858 starting material Substances 0.000 description 7
• BDZBKCUKTQZUTL-UHFFFAOYSA-N triethyl phosphite Chemical compound CCOP(OCC)OCC BDZBKCUKTQZUTL-UHFFFAOYSA-N 0.000 description 7
• QYIMSPSDBYKPPY-BANQPHDMSA-N 2,3-epoxysqualene Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C=C(/C)CC\C=C(/C)CCC1OC1(C)C QYIMSPSDBYKPPY-BANQPHDMSA-N 0.000 description 6
• MFXWOYIWKNJHPC-UHFFFAOYSA-N 4-(diethoxyphosphorylmethyl)benzonitrile Chemical compound CCOP(=O)(OCC)CC1=CC=C(C#N)C=C1 MFXWOYIWKNJHPC-UHFFFAOYSA-N 0.000 description 6
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
• 241000699800 Cricetinae Species 0.000 description 6
• 208000035150 Hypercholesterolemia Diseases 0.000 description 6
• 206010028980 Neoplasm Diseases 0.000 description 6
• KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
• 230000000694 effects Effects 0.000 description 6
• IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 6
• 229910000041 hydrogen chloride Inorganic materials 0.000 description 6
• 230000003463 hyperproliferative effect Effects 0.000 description 6
• 230000000927 lithogenic effect Effects 0.000 description 6
• 239000012074 organic phase Substances 0.000 description 6
• 239000000843 powder Substances 0.000 description 6
• 238000010992 reflux Methods 0.000 description 6
• 208000017520 skin disease Diseases 0.000 description 6
• 239000000829 suppository Substances 0.000 description 6
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 5
• RKIDDEGICSMIJA-UHFFFAOYSA-N 4-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C=C1 RKIDDEGICSMIJA-UHFFFAOYSA-N 0.000 description 5
• 102000004190 Enzymes Human genes 0.000 description 5
• 108090000790 Enzymes Proteins 0.000 description 5
• 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 5
• KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
• 229930182558 Sterol Natural products 0.000 description 5
• 239000004480 active ingredient Substances 0.000 description 5
• 239000002585 base Substances 0.000 description 5
• 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 5
• 210000000941 bile Anatomy 0.000 description 5
• 239000003795 chemical substances by application Substances 0.000 description 5
• 230000008686 ergosterol biosynthesis Effects 0.000 description 5
• 230000002538 fungal effect Effects 0.000 description 5
• 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 5
• BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 5
• 239000002244 precipitate Substances 0.000 description 5
• 239000012312 sodium hydride Substances 0.000 description 5
• 229910000104 sodium hydride Inorganic materials 0.000 description 5
• 150000003431 steroids Chemical class 0.000 description 5
• 235000003702 sterols Nutrition 0.000 description 5
• VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
• XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 4
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
• PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 4
• 230000000326 anti-hypercholesterolaemic effect Effects 0.000 description 4
• GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
• 239000003054 catalyst Substances 0.000 description 4
• 238000001704 evaporation Methods 0.000 description 4
• 230000008020 evaporation Effects 0.000 description 4
• 239000006260 foam Substances 0.000 description 4
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
• 239000002609 medium Substances 0.000 description 4
• 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 4
• 229940096701 plain lipid modifying drug hmg coa reductase inhibitors Drugs 0.000 description 4
• 229920001592 potato starch Polymers 0.000 description 4
• 239000011541 reaction mixture Substances 0.000 description 4
• 230000009467 reduction Effects 0.000 description 4
• 150000003432 sterols Chemical class 0.000 description 4
• RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical group C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
• OHJYFSWUYYTNEE-UHFFFAOYSA-N 4-[[1-(4-chlorobenzoyl)piperidin-4-ylidene]methyl]benzonitrile Chemical compound C1=CC(Cl)=CC=C1C(=O)N(CC1)CCC1=CC1=CC=C(C#N)C=C1 OHJYFSWUYYTNEE-UHFFFAOYSA-N 0.000 description 3
• 206010004146 Basal cell carcinoma Diseases 0.000 description 3
• 239000004342 Benzoyl peroxide Substances 0.000 description 3
• OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 3
• 229940126062 Compound A Drugs 0.000 description 3
• NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 3
• 102000004286 Hydroxymethylglutaryl CoA Reductases Human genes 0.000 description 3
• 108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 description 3
• 206010020649 Hyperkeratosis Diseases 0.000 description 3
• 208000001126 Keratosis Diseases 0.000 description 3
• 241001465754 Metazoa Species 0.000 description 3
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
• TUZYXOIXSAXUGO-UHFFFAOYSA-N Pravastatin Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(O)C=C21 TUZYXOIXSAXUGO-UHFFFAOYSA-N 0.000 description 3
• 201000004681 Psoriasis Diseases 0.000 description 3
• RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
• RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 3
• 102000005782 Squalene Monooxygenase Human genes 0.000 description 3
• 108020003891 Squalene monooxygenase Proteins 0.000 description 3
• 229960000583 acetic acid Drugs 0.000 description 3
• 150000001412 amines Chemical class 0.000 description 3
• 229940121375 antifungal agent Drugs 0.000 description 3
• 239000008346 aqueous phase Substances 0.000 description 3
• 230000003143 atherosclerotic effect Effects 0.000 description 3
• 235000019400 benzoyl peroxide Nutrition 0.000 description 3
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
• 230000004071 biological effect Effects 0.000 description 3
• 238000009835 boiling Methods 0.000 description 3
• 229910052794 bromium Inorganic materials 0.000 description 3
• 239000002775 capsule Substances 0.000 description 3
• 229950005499 carbon tetrachloride Drugs 0.000 description 3
• 201000001883 cholelithiasis Diseases 0.000 description 3
• 208000029078 coronary artery disease Diseases 0.000 description 3
• 235000005911 diet Nutrition 0.000 description 3
• 230000037213 diet Effects 0.000 description 3
• UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
• 239000008298 dragée Substances 0.000 description 3
• 210000002615 epidermis Anatomy 0.000 description 3
• 150000002148 esters Chemical class 0.000 description 3
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
• 238000005259 measurement Methods 0.000 description 3
• 239000003921 oil Substances 0.000 description 3
• 235000019198 oils Nutrition 0.000 description 3
• 239000012071 phase Substances 0.000 description 3
• NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 3
• 238000009374 poultry farming Methods 0.000 description 3
• 229960002965 pravastatin Drugs 0.000 description 3
• TUZYXOIXSAXUGO-PZAWKZKUSA-N pravastatin Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@H](O)C=C21 TUZYXOIXSAXUGO-PZAWKZKUSA-N 0.000 description 3
• 230000035755 proliferation Effects 0.000 description 3
• 125000006239 protecting group Chemical group 0.000 description 3
• 238000000746 purification Methods 0.000 description 3
• 238000007363 ring formation reaction Methods 0.000 description 3
• 238000007127 saponification reaction Methods 0.000 description 3
• 229960002855 simvastatin Drugs 0.000 description 3
• RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 3
• ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 3
• 235000011121 sodium hydroxide Nutrition 0.000 description 3
• 239000000725 suspension Substances 0.000 description 3
• VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 3
• 238000002560 therapeutic procedure Methods 0.000 description 3
• WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 3
• 229910052721 tungsten Inorganic materials 0.000 description 3
• 239000010937 tungsten Substances 0.000 description 3
• 230000002792 vascular Effects 0.000 description 3
• 208000019553 vascular disease Diseases 0.000 description 3
• 229910052727 yttrium Inorganic materials 0.000 description 3
• BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 2
• HXKKHQJGJAFBHI-GSVOUGTGSA-N (2R)-1-aminopropan-2-ol Chemical compound C[C@@H](O)CN HXKKHQJGJAFBHI-GSVOUGTGSA-N 0.000 description 2
• XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 2
• HXKKHQJGJAFBHI-VKHMYHEASA-N (2s)-1-aminopropan-2-ol Chemical compound C[C@H](O)CN HXKKHQJGJAFBHI-VKHMYHEASA-N 0.000 description 2
• CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 2
• RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 description 2
• XFVVPAFOKRTDIL-UHFFFAOYSA-N (4-bromophenyl)-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]methanone Chemical compound C1=CC(Br)=CC=C1C(=O)N(CC1)CCC1=CC1=CC=C(C=2OCCN=2)C=C1 XFVVPAFOKRTDIL-UHFFFAOYSA-N 0.000 description 2
• NFJBSWYEUWBJSE-UHFFFAOYSA-N (4-chlorophenyl)-[3-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)N(CCC1)CC1=CC1=CC=C(C=2OCCN=2)C=C1 NFJBSWYEUWBJSE-UHFFFAOYSA-N 0.000 description 2
• SHVMDJRPQSJXKI-UHFFFAOYSA-N (4-chlorophenyl)-[4-[1-[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]ethylidene]piperidin-1-yl]methanone Chemical group C=1C=C(C=2OCCN=2)C=CC=1C(C)=C(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 SHVMDJRPQSJXKI-UHFFFAOYSA-N 0.000 description 2
• JCZWHCSNHNFMHY-UHFFFAOYSA-N (4-chlorophenyl)-[4-[[4-(4,5-dihydro-1,3-thiazol-2-yl)phenyl]methyl]piperidin-1-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)N1CCC(CC=2C=CC(=CC=2)C=2SCCN=2)CC1 JCZWHCSNHNFMHY-UHFFFAOYSA-N 0.000 description 2
• WXLAMGVZTQDOCI-UHFFFAOYSA-N (4-chlorophenyl)-[4-[[4-(5-phenyl-4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)N(CC1)CCC1=CC1=CC=C(C=2OC(CN=2)C=2C=CC=CC=2)C=C1 WXLAMGVZTQDOCI-UHFFFAOYSA-N 0.000 description 2
• AGFWPKXAVVLFQV-MRXNPFEDSA-N (4-chlorophenyl)-[4-[[4-[(4r)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]phenyl]methylidene]piperidin-1-yl]methanone Chemical group C[C@@H]1COC(C=2C=CC(C=C3CCN(CC3)C(=O)C=3C=CC(Cl)=CC=3)=CC=2)=N1 AGFWPKXAVVLFQV-MRXNPFEDSA-N 0.000 description 2
• FXUWKHOFWXKFBP-UHFFFAOYSA-N (4-chlorophenyl)-[4-[[4-[4-(hydroxymethyl)-4,5-dihydro-1,3-oxazol-2-yl]phenyl]methylidene]piperidin-1-yl]methanone Chemical group OCC1COC(C=2C=CC(C=C3CCN(CC3)C(=O)C=3C=CC(Cl)=CC=3)=CC=2)=N1 FXUWKHOFWXKFBP-UHFFFAOYSA-N 0.000 description 2
• MNWXZHHJKAHJFH-UHFFFAOYSA-N (4-chlorophenyl)-[4-[[4-[5-(diethylaminomethyl)-4,5-dihydro-1,3-oxazol-2-yl]phenyl]methylidene]piperidin-1-yl]methanone Chemical group O1C(CN(CC)CC)CN=C1C(C=C1)=CC=C1C=C1CCN(C(=O)C=2C=CC(Cl)=CC=2)CC1 MNWXZHHJKAHJFH-UHFFFAOYSA-N 0.000 description 2
• AHZGEYJLRDXCFQ-UHFFFAOYSA-N (4-tert-butylphenyl)-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]methanone Chemical group C1=CC(C(C)(C)C)=CC=C1C(=O)N(CC1)CCC1=CC1=CC=C(C=2OCCN=2)C=C1 AHZGEYJLRDXCFQ-UHFFFAOYSA-N 0.000 description 2
• KJTLQQUUPVSXIM-ZCFIWIBFSA-N (R)-mevalonic acid Chemical compound OCC[C@](O)(C)CC(O)=O KJTLQQUUPVSXIM-ZCFIWIBFSA-N 0.000 description 2
• BKMMTJMQCTUHRP-VKHMYHEASA-N (S)-2-aminopropan-1-ol Chemical compound C[C@H](N)CO BKMMTJMQCTUHRP-VKHMYHEASA-N 0.000 description 2
• KIRGLCXNEVICOG-SOFGYWHQSA-N (e)-n-ethyl-6,6-dimethyl-n-[[3-[(4-thiophen-3-ylthiophen-2-yl)methoxy]phenyl]methyl]hept-2-en-4-yn-1-amine Chemical compound CC(C)(C)C#C/C=C/CN(CC)CC1=CC=CC(OCC=2SC=C(C=2)C2=CSC=C2)=C1 KIRGLCXNEVICOG-SOFGYWHQSA-N 0.000 description 2
• GAKRFXBXTBSAOJ-UHFFFAOYSA-N 1-(2,2-dimethylpropanoyl)piperidin-4-one Chemical compound CC(C)(C)C(=O)N1CCC(=O)CC1 GAKRFXBXTBSAOJ-UHFFFAOYSA-N 0.000 description 2
• SGPVWOVMGWACSW-UHFFFAOYSA-N 1-(4-chlorophenyl)sulfonyl-4-[[4-(4,5-dihydro-1h-imidazol-2-yl)phenyl]methylidene]piperidine Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)N(CC1)CCC1=CC1=CC=C(C=2NCCN=2)C=C1 SGPVWOVMGWACSW-UHFFFAOYSA-N 0.000 description 2
• MBFQWKZGVWXLGM-UHFFFAOYSA-N 1-(4-chlorophenyl)sulfonylpiperidin-4-one Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)N1CCC(=O)CC1 MBFQWKZGVWXLGM-UHFFFAOYSA-N 0.000 description 2
• SYWXLNAOEXIDMG-UHFFFAOYSA-N 1-(4-methylbenzoyl)piperidin-4-one Chemical compound C1=CC(C)=CC=C1C(=O)N1CCC(=O)CC1 SYWXLNAOEXIDMG-UHFFFAOYSA-N 0.000 description 2
• YPJLJUYIXVELMP-UHFFFAOYSA-N 1-(cyclohexanecarbonyl)piperidin-4-one Chemical compound C1CC(=O)CCN1C(=O)C1CCCCC1 YPJLJUYIXVELMP-UHFFFAOYSA-N 0.000 description 2
• XNQQHFAOMVVKLL-UHFFFAOYSA-N 1-[3-(4-chlorophenyl)prop-2-enoyl]piperidin-4-one Chemical compound C1=CC(Cl)=CC=C1C=CC(=O)N1CCC(=O)CC1 XNQQHFAOMVVKLL-UHFFFAOYSA-N 0.000 description 2
• OKFOMVUJXRVXKT-UHFFFAOYSA-N 1-hexanoylpiperidin-4-one Chemical compound CCCCCC(=O)N1CCC(=O)CC1 OKFOMVUJXRVXKT-UHFFFAOYSA-N 0.000 description 2
• XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 2
• DCXHJGKFDUCLFN-UHFFFAOYSA-N 2-(4-chlorophenyl)-1-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]ethanone Chemical compound C1=CC(Cl)=CC=C1CC(=O)N(CC1)CCC1=CC1=CC=C(C=2OCCN=2)C=C1 DCXHJGKFDUCLFN-UHFFFAOYSA-N 0.000 description 2
• UIEDZUKCXHRVOA-UHFFFAOYSA-N 2-[4-(azepan-4-ylidenemethyl)phenyl]-4,5-dihydro-1,3-oxazole Chemical compound O1CCN=C1C(C=C1)=CC=C1C=C1CCNCCC1 UIEDZUKCXHRVOA-UHFFFAOYSA-N 0.000 description 2
• JQVVKESCKMKHNO-UHFFFAOYSA-N 2-[4-[(1-tritylazepan-4-ylidene)methyl]phenyl]-4,5-dihydro-1,3-oxazole Chemical compound O1CCN=C1C(C=C1)=CC=C1C=C1CCN(C(C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)CCC1 JQVVKESCKMKHNO-UHFFFAOYSA-N 0.000 description 2
• KMFZBIDLKORZFY-UHFFFAOYSA-N 2-[4-[(1-tritylpiperidin-4-ylidene)methyl]phenyl]-4,5-dihydro-1,3-oxazole Chemical compound O1CCN=C1C(C=C1)=CC=C1C=C1CCN(C(C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 KMFZBIDLKORZFY-UHFFFAOYSA-N 0.000 description 2
• PMCPUVUCNRWQFZ-UHFFFAOYSA-N 2-[4-[[1-(4-chlorophenyl)sulfonylpiperidin-4-ylidene]methyl]phenyl]-4,5-dihydro-1,3-oxazole Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)N(CC1)CCC1=CC1=CC=C(C=2OCCN=2)C=C1 PMCPUVUCNRWQFZ-UHFFFAOYSA-N 0.000 description 2
• ZPUYDPWWJCNLFT-UHFFFAOYSA-N 3-(diethoxyphosphorylmethyl)benzonitrile Chemical compound CCOP(=O)(OCC)CC1=CC=CC(C#N)=C1 ZPUYDPWWJCNLFT-UHFFFAOYSA-N 0.000 description 2
• DZEVNTXRKRZJAH-UHFFFAOYSA-N 3-[[1-(4-chlorobenzoyl)piperidin-4-ylidene]methyl]benzonitrile Chemical compound C1=CC(Cl)=CC=C1C(=O)N(CC1)CCC1=CC1=CC=CC(C#N)=C1 DZEVNTXRKRZJAH-UHFFFAOYSA-N 0.000 description 2
• RWSFTZLGMGVCQW-UHFFFAOYSA-N 3-bromo-4-[[1-(4-chlorobenzoyl)piperidin-4-ylidene]methyl]-n-(2-hydroxyethyl)benzamide Chemical compound BrC1=CC(C(=O)NCCO)=CC=C1C=C1CCN(C(=O)C=2C=CC(Cl)=CC=2)CC1 RWSFTZLGMGVCQW-UHFFFAOYSA-N 0.000 description 2
• WHIHIKVIWVIIER-UHFFFAOYSA-N 3-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=CC(Cl)=C1 WHIHIKVIWVIIER-UHFFFAOYSA-N 0.000 description 2
• FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 2
• ILVPJQJMEHTPAU-UHFFFAOYSA-N 4-(1-diethoxyphosphorylethyl)benzonitrile Chemical compound CCOP(=O)(OCC)C(C)C1=CC=C(C#N)C=C1 ILVPJQJMEHTPAU-UHFFFAOYSA-N 0.000 description 2
• FMAUUDCCCFDYNW-UHFFFAOYSA-N 4-[(1-benzylpiperidin-3-ylidene)methyl]benzonitrile Chemical compound C1=CC(C#N)=CC=C1C=C1CN(CC=2C=CC=CC=2)CCC1 FMAUUDCCCFDYNW-UHFFFAOYSA-N 0.000 description 2
• IKCNXAZOERQIST-UHFFFAOYSA-N 4-[1-[1-(4-chlorobenzoyl)piperidin-4-ylidene]ethyl]benzonitrile Chemical compound C=1C=C(C#N)C=CC=1C(C)=C(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 IKCNXAZOERQIST-UHFFFAOYSA-N 0.000 description 2
• KZUVDSMISYKGPQ-UHFFFAOYSA-N 4-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidine-1-carbonyl]benzonitrile Chemical group C=1C=C(C#N)C=CC=1C(=O)N(CC1)CCC1=CC(C=C1)=CC=C1C1=NCCO1 KZUVDSMISYKGPQ-UHFFFAOYSA-N 0.000 description 2
• XIHNYSZNFSAEFS-UHFFFAOYSA-N 4-[[1-(4-chlorobenzoyl)piperidin-3-ylidene]methyl]benzonitrile Chemical compound C1=CC(Cl)=CC=C1C(=O)N(CCC1)CC1=CC1=CC=C(C#N)C=C1 XIHNYSZNFSAEFS-UHFFFAOYSA-N 0.000 description 2
• MUONSSYIIKRISA-UHFFFAOYSA-N 4-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]benzonitrile Chemical compound C1=CC(Cl)=CC=C1C(=O)N1CCC(CC=2C=CC(=CC=2)C#N)CC1 MUONSSYIIKRISA-UHFFFAOYSA-N 0.000 description 2
• YYBSMBQJOZXDKF-UHFFFAOYSA-N 4-[[1-(4-chlorobenzoyl)piperidin-4-ylidene]methyl]-3-fluoro-n-(2-hydroxyethyl)benzamide Chemical compound FC1=CC(C(=O)NCCO)=CC=C1C=C1CCN(C(=O)C=2C=CC(Cl)=CC=2)CC1 YYBSMBQJOZXDKF-UHFFFAOYSA-N 0.000 description 2
• NCKKTZWXJHKUGQ-UHFFFAOYSA-N 4-[[1-(4-chlorobenzoyl)piperidin-4-ylidene]methyl]-n-(2-hydroxyethyl)-2-methylbenzamide Chemical compound C1=C(C(=O)NCCO)C(C)=CC(C=C2CCN(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1 NCKKTZWXJHKUGQ-UHFFFAOYSA-N 0.000 description 2
• OPJFKRXUCJCIBZ-UHFFFAOYSA-N 4-[[1-(4-chlorobenzoyl)piperidin-4-ylidene]methyl]-n-(2-hydroxyethyl)-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCO)=CC=C1C=C1CCN(C(=O)C=2C=CC(Cl)=CC=2)CC1 OPJFKRXUCJCIBZ-UHFFFAOYSA-N 0.000 description 2
• USEDMAWWQDFMFY-UHFFFAOYSA-N 4-cyanobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(C#N)C=C1 USEDMAWWQDFMFY-UHFFFAOYSA-N 0.000 description 2
• CZKLEJHVLCMVQR-UHFFFAOYSA-N 4-fluorobenzoyl chloride Chemical compound FC1=CC=C(C(Cl)=O)C=C1 CZKLEJHVLCMVQR-UHFFFAOYSA-N 0.000 description 2
• NQUVCRCCRXRJCK-UHFFFAOYSA-N 4-methylbenzoyl chloride Chemical compound CC1=CC=C(C(Cl)=O)C=C1 NQUVCRCCRXRJCK-UHFFFAOYSA-N 0.000 description 2
• WNLMYNASWOULQY-UHFFFAOYSA-N 4-tert-butylbenzoyl chloride Chemical compound CC(C)(C)C1=CC=C(C(Cl)=O)C=C1 WNLMYNASWOULQY-UHFFFAOYSA-N 0.000 description 2
• VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
• 201000001320 Atherosclerosis Diseases 0.000 description 2
• 206010008120 Cerebral ischaemia Diseases 0.000 description 2
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
• KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 description 2
• QRLVDLBMBULFAL-UHFFFAOYSA-N Digitonin Natural products CC1CCC2(OC1)OC3C(O)C4C5CCC6CC(OC7OC(CO)C(OC8OC(CO)C(O)C(OC9OCC(O)C(O)C9OC%10OC(CO)C(O)C(OC%11OC(CO)C(O)C(O)C%11O)C%10O)C8O)C(O)C7O)C(O)CC6(C)C5CCC4(C)C3C2C QRLVDLBMBULFAL-UHFFFAOYSA-N 0.000 description 2
• PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 2
• 206010017711 Gangrene Diseases 0.000 description 2
• BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 2
• 206010022562 Intermittent claudication Diseases 0.000 description 2
• LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 2
• CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 2
• PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
• CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
• WUGQZFFCHPXWKQ-UHFFFAOYSA-N Propanolamine Chemical compound NCCCO WUGQZFFCHPXWKQ-UHFFFAOYSA-N 0.000 description 2
• 241000700159 Rattus Species 0.000 description 2
• SMCBPTINXPSTME-UHFFFAOYSA-N [4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]-(2,3,4,5,6-pentafluorophenyl)methanone Chemical compound FC1=C(F)C(F)=C(F)C(F)=C1C(=O)N(CC1)CCC1=CC1=CC=C(C=2OCCN=2)C=C1 SMCBPTINXPSTME-UHFFFAOYSA-N 0.000 description 2
• NUCGZOYEHKVDRG-UHFFFAOYSA-N [4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]-(4-methoxyphenyl)methanone Chemical compound C1=CC(OC)=CC=C1C(=O)N(CC1)CCC1=CC1=CC=C(C=2OCCN=2)C=C1 NUCGZOYEHKVDRG-UHFFFAOYSA-N 0.000 description 2
• ZUNIULHRTLIRSX-UHFFFAOYSA-N [4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]-(4-nitrophenyl)methanone Chemical group C1=CC([N+](=O)[O-])=CC=C1C(=O)N(CC1)CCC1=CC1=CC=C(C=2OCCN=2)C=C1 ZUNIULHRTLIRSX-UHFFFAOYSA-N 0.000 description 2
• BXWKAKAGLXTNES-UHFFFAOYSA-N [4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]-naphthalen-1-ylmethanone Chemical compound C=1C=CC2=CC=CC=C2C=1C(=O)N(CC1)CCC1=CC(C=C1)=CC=C1C1=NCCO1 BXWKAKAGLXTNES-UHFFFAOYSA-N 0.000 description 2
• KPJBJDQCDGBJHP-UHFFFAOYSA-N [4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]-phenylmethanone Chemical compound C=1C=CC=CC=1C(=O)N(CC1)CCC1=CC(C=C1)=CC=C1C1=NCCO1 KPJBJDQCDGBJHP-UHFFFAOYSA-N 0.000 description 2
• 239000002253 acid Substances 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 150000001298 alcohols Chemical class 0.000 description 2
• 239000003242 anti bacterial agent Substances 0.000 description 2
• 229940088710 antibiotic agent Drugs 0.000 description 2
• PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 2
• 239000003613 bile acid Substances 0.000 description 2
• 239000011230 binding agent Substances 0.000 description 2
• XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Chemical compound [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 2
• 229910000019 calcium carbonate Inorganic materials 0.000 description 2
• 239000007795 chemical reaction product Substances 0.000 description 2
• QOPVNWQGBQYBBP-UHFFFAOYSA-N chloroethyl chloroformate Chemical compound CC(Cl)OC(Cl)=O QOPVNWQGBQYBBP-UHFFFAOYSA-N 0.000 description 2
• IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 2
• 239000003245 coal Substances 0.000 description 2
• 239000006071 cream Substances 0.000 description 2
• UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 2
• UVYVLBIGDKGWPX-KUAJCENISA-N digitonin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O[C@H]5[C@@H]([C@@H](O)[C@@H](O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)CO7)O)[C@H](O)[C@@H](CO)O6)O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O7)O)[C@@H](O)[C@@H](CO)O6)O)[C@@H](CO)O5)O)C[C@@H]4CC[C@H]3[C@@H]2[C@@H]1O)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 UVYVLBIGDKGWPX-KUAJCENISA-N 0.000 description 2
• UVYVLBIGDKGWPX-UHFFFAOYSA-N digitonine Natural products CC1C(C2(CCC3C4(C)CC(O)C(OC5C(C(O)C(OC6C(C(OC7C(C(O)C(O)CO7)O)C(O)C(CO)O6)OC6C(C(OC7C(C(O)C(O)C(CO)O7)O)C(O)C(CO)O6)O)C(CO)O5)O)CC4CCC3C2C2O)C)C2OC11CCC(C)CO1 UVYVLBIGDKGWPX-UHFFFAOYSA-N 0.000 description 2
• QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 2
• POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 2
• 239000000839 emulsion Substances 0.000 description 2
• 125000004185 ester group Chemical group 0.000 description 2
• 229940125753 fibrate Drugs 0.000 description 2
• 239000000706 filtrate Substances 0.000 description 2
• RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 2
• 229960004884 fluconazole Drugs 0.000 description 2
• 230000000855 fungicidal effect Effects 0.000 description 2
• 230000001408 fungistatic effect Effects 0.000 description 2
• 239000008187 granular material Substances 0.000 description 2
• 230000012010 growth Effects 0.000 description 2
• 229910000039 hydrogen halide Inorganic materials 0.000 description 2
• 239000012433 hydrogen halide Substances 0.000 description 2
• 230000000871 hypocholesterolemic effect Effects 0.000 description 2
• 239000005457 ice water Substances 0.000 description 2
• 238000001727 in vivo Methods 0.000 description 2
• 238000010348 incorporation Methods 0.000 description 2
• 238000011534 incubation Methods 0.000 description 2
• 239000012442 inert solvent Substances 0.000 description 2
• 230000002757 inflammatory effect Effects 0.000 description 2
• 238000011835 investigation Methods 0.000 description 2
• 229910052740 iodine Inorganic materials 0.000 description 2
• 230000003780 keratinization Effects 0.000 description 2
• 210000002510 keratinocyte Anatomy 0.000 description 2
• 229960004125 ketoconazole Drugs 0.000 description 2
• 150000002576 ketones Chemical class 0.000 description 2
• CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 2
• 229940058690 lanosterol Drugs 0.000 description 2
• 239000012280 lithium aluminium hydride Substances 0.000 description 2
• 235000019359 magnesium stearate Nutrition 0.000 description 2
• 210000004962 mammalian cell Anatomy 0.000 description 2
• 229960003151 mercaptamine Drugs 0.000 description 2
• JYRMLIYMFJQZDX-UHFFFAOYSA-N methyl 3-bromo-4-(diethoxyphosphorylmethyl)benzoate Chemical compound CCOP(=O)(OCC)CC1=CC=C(C(=O)OC)C=C1Br JYRMLIYMFJQZDX-UHFFFAOYSA-N 0.000 description 2
• UETCOAOCGJDHDF-UHFFFAOYSA-N methyl 3-bromo-4-[[1-(4-chlorobenzoyl)piperidin-4-ylidene]methyl]benzoate Chemical compound BrC1=CC(C(=O)OC)=CC=C1C=C1CCN(C(=O)C=2C=CC(Cl)=CC=2)CC1 UETCOAOCGJDHDF-UHFFFAOYSA-N 0.000 description 2
• LWQYEPVYVLDPQY-UHFFFAOYSA-N methyl 4-(diethoxyphosphorylmethyl)-2-methylbenzoate Chemical compound CCOP(=O)(OCC)CC1=CC=C(C(=O)OC)C(C)=C1 LWQYEPVYVLDPQY-UHFFFAOYSA-N 0.000 description 2
• BNAFOHSNCMFBOU-UHFFFAOYSA-N methyl 4-(diethoxyphosphorylmethyl)-3-fluorobenzoate Chemical compound CCOP(=O)(OCC)CC1=CC=C(C(=O)OC)C=C1F BNAFOHSNCMFBOU-UHFFFAOYSA-N 0.000 description 2
• STRLWTVZXMRWIX-UHFFFAOYSA-N methyl 4-(diethoxyphosphorylmethyl)-3-methoxybenzoate Chemical compound CCOP(=O)(OCC)CC1=CC=C(C(=O)OC)C=C1OC STRLWTVZXMRWIX-UHFFFAOYSA-N 0.000 description 2
• KPTODDKVARZPAV-UHFFFAOYSA-N methyl 4-[[1-(4-chlorobenzoyl)piperidin-4-ylidene]methyl]-2-methylbenzoate Chemical compound C1=C(C)C(C(=O)OC)=CC=C1C=C1CCN(C(=O)C=2C=CC(Cl)=CC=2)CC1 KPTODDKVARZPAV-UHFFFAOYSA-N 0.000 description 2
• JYINJWRZBDFMGH-UHFFFAOYSA-N methyl 4-[[1-(4-chlorobenzoyl)piperidin-4-ylidene]methyl]-3-fluorobenzoate Chemical compound FC1=CC(C(=O)OC)=CC=C1C=C1CCN(C(=O)C=2C=CC(Cl)=CC=2)CC1 JYINJWRZBDFMGH-UHFFFAOYSA-N 0.000 description 2
• UMDMECGVNQUIDS-UHFFFAOYSA-N methyl 4-[[1-(4-chlorobenzoyl)piperidin-4-ylidene]methyl]-3-methoxybenzoate Chemical compound COC1=CC(C(=O)OC)=CC=C1C=C1CCN(C(=O)C=2C=CC(Cl)=CC=2)CC1 UMDMECGVNQUIDS-UHFFFAOYSA-N 0.000 description 2
• 210000004400 mucous membrane Anatomy 0.000 description 2
• KFIGICHILYTCJF-UHFFFAOYSA-N n'-methylethane-1,2-diamine Chemical compound CNCCN KFIGICHILYTCJF-UHFFFAOYSA-N 0.000 description 2
• OZGNYLLQHRPOBR-DHZHZOJOSA-N naftifine Chemical compound C=1C=CC2=CC=CC=C2C=1CN(C)C\C=C\C1=CC=CC=C1 OZGNYLLQHRPOBR-DHZHZOJOSA-N 0.000 description 2
• 229960004313 naftifine Drugs 0.000 description 2
• NSNPSJGHTQIXDO-UHFFFAOYSA-N naphthalene-1-carbonyl chloride Chemical compound C1=CC=C2C(C(=O)Cl)=CC=CC2=C1 NSNPSJGHTQIXDO-UHFFFAOYSA-N 0.000 description 2
• XNLBCXGRQWUJLU-UHFFFAOYSA-N naphthalene-2-carbonyl chloride Chemical compound C1=CC=CC2=CC(C(=O)Cl)=CC=C21 XNLBCXGRQWUJLU-UHFFFAOYSA-N 0.000 description 2
• 230000035407 negative regulation of cell proliferation Effects 0.000 description 2
• 231100000252 nontoxic Toxicity 0.000 description 2
• 150000007530 organic bases Chemical class 0.000 description 2
• 229910052763 palladium Inorganic materials 0.000 description 2
• ULSIYEODSMZIPX-UHFFFAOYSA-N phenylethanolamine Chemical compound NCC(O)C1=CC=CC=C1 ULSIYEODSMZIPX-UHFFFAOYSA-N 0.000 description 2
• 150000003904 phospholipids Chemical class 0.000 description 2
• 150000003053 piperidines Chemical class 0.000 description 2
• 229910052697 platinum Inorganic materials 0.000 description 2
• BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
• 238000001556 precipitation Methods 0.000 description 2
• BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
• 230000008844 regulatory mechanism Effects 0.000 description 2
• 238000009097 single-agent therapy Methods 0.000 description 2
• 210000000329 smooth muscle myocyte Anatomy 0.000 description 2
• 229910000029 sodium carbonate Inorganic materials 0.000 description 2
• 206010041823 squamous cell carcinoma Diseases 0.000 description 2
• 238000010561 standard procedure Methods 0.000 description 2
• DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 2
• 229960002722 terbinafine Drugs 0.000 description 2
• JJXKSFOFDFIQLM-UHFFFAOYSA-N tert-butyl 4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1=CC1=CC=C(C=2OCCN=2)C=C1 JJXKSFOFDFIQLM-UHFFFAOYSA-N 0.000 description 2
• 150000003512 tertiary amines Chemical class 0.000 description 2
• FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
• YSHOWEKUVWPFNR-UHFFFAOYSA-O triethyl(methoxycarbonylsulfamoyl)azanium Chemical compound CC[N+](CC)(CC)S(=O)(=O)NC(=O)OC YSHOWEKUVWPFNR-UHFFFAOYSA-O 0.000 description 2
• 230000001960 triggered effect Effects 0.000 description 2
• JBWKIWSBJXDJDT-UHFFFAOYSA-N triphenylmethyl chloride Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 JBWKIWSBJXDJDT-UHFFFAOYSA-N 0.000 description 2
• RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
• RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 description 2
• 229960001661 ursodiol Drugs 0.000 description 2
• 238000005303 weighing Methods 0.000 description 2
• 239000008096 xylene Substances 0.000 description 2
• KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
• QYGAYYORBSAYHS-UHFFFAOYSA-N (2,5-difluorophenyl)-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]methanone Chemical compound FC1=CC=C(F)C(C(=O)N2CCC(CC2)=CC=2C=CC(=CC=2)C=2OCCN=2)=C1 QYGAYYORBSAYHS-UHFFFAOYSA-N 0.000 description 1
• ZECUIPMZTFIVOA-UHFFFAOYSA-N (2-chlorophenyl)-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methyl]piperidin-1-yl]methanone Chemical compound ClC1=CC=CC=C1C(=O)N1CCC(CC=2C=CC(=CC=2)C=2OCCN=2)CC1 ZECUIPMZTFIVOA-UHFFFAOYSA-N 0.000 description 1
• CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
• OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
• RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
• STVVMTBJNDTZBF-SECBINFHSA-N (2r)-2-amino-3-phenylpropan-1-ol Chemical compound OC[C@H](N)CC1=CC=CC=C1 STVVMTBJNDTZBF-SECBINFHSA-N 0.000 description 1
• BKMMTJMQCTUHRP-GSVOUGTGSA-N (2r)-2-aminopropan-1-ol Chemical compound C[C@@H](N)CO BKMMTJMQCTUHRP-GSVOUGTGSA-N 0.000 description 1
• RPHQMRWKOPBZQY-VIFPVBQESA-N (2s)-2-amino-3-(4-chlorophenyl)propan-1-ol Chemical compound OC[C@@H](N)CC1=CC=C(Cl)C=C1 RPHQMRWKOPBZQY-VIFPVBQESA-N 0.000 description 1
• MIQJGZAEWQQAPN-YFKPBYRVSA-N (2s)-2-amino-4-methylsulfanylbutan-1-ol Chemical compound CSCC[C@H](N)CO MIQJGZAEWQQAPN-YFKPBYRVSA-N 0.000 description 1
• HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
• MFIHQEMSOWWULK-UHFFFAOYSA-N (3,4-dichlorophenyl)-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]methanone Chemical compound C1=C(Cl)C(Cl)=CC=C1C(=O)N(CC1)CCC1=CC1=CC=C(C=2OCCN=2)C=C1 MFIHQEMSOWWULK-UHFFFAOYSA-N 0.000 description 1
• OHZYOKBCFZAIAF-UHFFFAOYSA-N (3,4-difluorophenyl)-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]methanone Chemical compound C1=C(F)C(F)=CC=C1C(=O)N(CC1)CCC1=CC1=CC=C(C=2OCCN=2)C=C1 OHZYOKBCFZAIAF-UHFFFAOYSA-N 0.000 description 1
• KJOOPGBMLXPRPT-UHFFFAOYSA-N (3-chlorophenyl)-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methyl]piperidin-1-yl]methanone Chemical compound ClC1=CC=CC(C(=O)N2CCC(CC=3C=CC(=CC=3)C=3OCCN=3)CC2)=C1 KJOOPGBMLXPRPT-UHFFFAOYSA-N 0.000 description 1
• DKUJVSIXRNLXCN-UHFFFAOYSA-N (3-chlorophenyl)-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]methanone Chemical compound ClC1=CC=CC(C(=O)N2CCC(CC2)=CC=2C=CC(=CC=2)C=2OCCN=2)=C1 DKUJVSIXRNLXCN-UHFFFAOYSA-N 0.000 description 1
• IYTKDFVHGXIKPT-UHFFFAOYSA-N (4-chlorophenyl)-[3-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methyl]piperidin-1-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)N1CC(CC=2C=CC(=CC=2)C=2OCCN=2)CCC1 IYTKDFVHGXIKPT-UHFFFAOYSA-N 0.000 description 1
• ZAKWLCVMBNQLBM-UHFFFAOYSA-N (4-chlorophenyl)-[4-[[3-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)N(CC1)CCC1=CC1=CC=CC(C=2OCCN=2)=C1 ZAKWLCVMBNQLBM-UHFFFAOYSA-N 0.000 description 1
• XJAKFPRVKFQHKH-UHFFFAOYSA-N (4-chlorophenyl)-[4-[[4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]methyl]piperidin-1-yl]methanone Chemical compound CN1CCN=C1C(C=C1)=CC=C1CC1CCN(C(=O)C=2C=CC(Cl)=CC=2)CC1 XJAKFPRVKFQHKH-UHFFFAOYSA-N 0.000 description 1
• VOLRAJLJVUHNBQ-UHFFFAOYSA-N (4-chlorophenyl)-[4-[[4-(4,4-dimethyl-5h-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]methanone Chemical compound CC1(C)COC(C=2C=CC(C=C3CCN(CC3)C(=O)C=3C=CC(Cl)=CC=3)=CC=2)=N1 VOLRAJLJVUHNBQ-UHFFFAOYSA-N 0.000 description 1
• DWSIFHMPCNSTNR-UHFFFAOYSA-N (4-chlorophenyl)-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]azepan-1-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)N(CCC1)CCC1=CC1=CC=C(C=2OCCN=2)C=C1 DWSIFHMPCNSTNR-UHFFFAOYSA-N 0.000 description 1
• NFIJVSVPTQOVQJ-UHFFFAOYSA-N (4-chlorophenyl)-[4-[[4-(4,5-dihydro-1,3-thiazol-2-yl)phenyl]methylidene]piperidin-1-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)N(CC1)CCC1=CC1=CC=C(C=2SCCN=2)C=C1 NFIJVSVPTQOVQJ-UHFFFAOYSA-N 0.000 description 1
• PBVSLSKYECYUAV-UHFFFAOYSA-N (4-chlorophenyl)-[4-[[4-(4,5-dihydro-1h-imidazol-2-yl)phenyl]methyl]piperidin-1-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)N1CCC(CC=2C=CC(=CC=2)C=2NCCN=2)CC1 PBVSLSKYECYUAV-UHFFFAOYSA-N 0.000 description 1
• XFOCSOLDOUGPES-UHFFFAOYSA-N (4-chlorophenyl)-[4-[[4-(5,5-dimethyl-4h-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]methanone Chemical compound O1C(C)(C)CN=C1C(C=C1)=CC=C1C=C1CCN(C(=O)C=2C=CC(Cl)=CC=2)CC1 XFOCSOLDOUGPES-UHFFFAOYSA-N 0.000 description 1
• VVSBYEFOJCOZSY-UHFFFAOYSA-N (4-chlorophenyl)-[4-[[4-(oxazinan-2-yl)phenyl]methyl]piperidin-1-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)N1CCC(CC=2C=CC(=CC=2)N2OCCCC2)CC1 VVSBYEFOJCOZSY-UHFFFAOYSA-N 0.000 description 1
• QMVAZSLFXUGWQR-SANMLTNESA-N (4-chlorophenyl)-[4-[[4-[(4r)-4-phenyl-4,5-dihydro-1,3-oxazol-2-yl]phenyl]methylidene]piperidin-1-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)N(CC1)CCC1=CC1=CC=C(C=2OC[C@H](N=2)C=2C=CC=CC=2)C=C1 QMVAZSLFXUGWQR-SANMLTNESA-N 0.000 description 1
• IEJSZZDGLVWNCE-MRXNPFEDSA-N (4-chlorophenyl)-[4-[[4-[(5r)-5-methyl-4,5-dihydro-1,3-oxazol-2-yl]phenyl]methyl]piperidin-1-yl]methanone Chemical compound O1[C@H](C)CN=C1C(C=C1)=CC=C1CC1CCN(C(=O)C=2C=CC(Cl)=CC=2)CC1 IEJSZZDGLVWNCE-MRXNPFEDSA-N 0.000 description 1
• GRZUFZBZZLJFDX-MRXNPFEDSA-N (4-chlorophenyl)-[4-[[4-[(5r)-5-methyl-4,5-dihydro-1,3-oxazol-2-yl]phenyl]methylidene]piperidin-1-yl]methanone Chemical compound O1[C@H](C)CN=C1C(C=C1)=CC=C1C=C1CCN(C(=O)C=2C=CC(Cl)=CC=2)CC1 GRZUFZBZZLJFDX-MRXNPFEDSA-N 0.000 description 1
• NHYQZHCWVXPQQN-UHFFFAOYSA-N (4-chlorophenyl)-[4-[[4-[4-(2-methylsulfanylethyl)-4,5-dihydro-1,3-oxazol-2-yl]phenyl]methylidene]piperidin-1-yl]methanone Chemical compound CSCCC1COC(C=2C=CC(C=C3CCN(CC3)C(=O)C=3C=CC(Cl)=CC=3)=CC=2)=N1 NHYQZHCWVXPQQN-UHFFFAOYSA-N 0.000 description 1
• NOLBOXVHBSSDQL-UHFFFAOYSA-N (4-chlorophenyl)-[4-[[4-[4-[(4-chlorophenyl)methyl]-4,5-dihydro-1,3-oxazol-2-yl]phenyl]methylidene]piperidin-1-yl]methanone Chemical compound C1=CC(Cl)=CC=C1CC1N=C(C=2C=CC(C=C3CCN(CC3)C(=O)C=3C=CC(Cl)=CC=3)=CC=2)OC1 NOLBOXVHBSSDQL-UHFFFAOYSA-N 0.000 description 1
• LHXXHNXEIDHTJS-UHFFFAOYSA-N (4-tert-butylphenyl)-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methyl]piperidin-1-yl]methanone Chemical compound C1=CC(C(C)(C)C)=CC=C1C(=O)N1CCC(CC=2C=CC(=CC=2)C=2OCCN=2)CC1 LHXXHNXEIDHTJS-UHFFFAOYSA-N 0.000 description 1
• OBYAAZRQFIVRJS-GUUMBNHASA-N (4e,8e,12z,16z)-n,n,4,8,13,17,21-heptamethyldocosa-4,8,12,16,20-pentaen-1-amine Chemical compound CN(C)CCC\C(C)=C\CC\C(C)=C\CC\C=C(/C)CC\C=C(/C)CCC=C(C)C OBYAAZRQFIVRJS-GUUMBNHASA-N 0.000 description 1
• IJXJGQCXFSSHNL-QMMMGPOBSA-N (R)-(-)-2-Phenylglycinol Chemical compound OC[C@H](N)C1=CC=CC=C1 IJXJGQCXFSSHNL-QMMMGPOBSA-N 0.000 description 1
• PSCXFXNEYIHJST-QPJJXVBHSA-N (e)-4-phenylbut-3-enoic acid Chemical compound OC(=O)C\C=C\C1=CC=CC=C1 PSCXFXNEYIHJST-QPJJXVBHSA-N 0.000 description 1
• USVVENVKYJZFMW-ONEGZZNKSA-N (e)-carboxyiminocarbamic acid Chemical compound OC(=O)\N=N\C(O)=O USVVENVKYJZFMW-ONEGZZNKSA-N 0.000 description 1
• STVVMTBJNDTZBF-UHFFFAOYSA-N -2-Amino-3-phenyl-1-propanol Natural products OCC(N)CC1=CC=CC=C1 STVVMTBJNDTZBF-UHFFFAOYSA-N 0.000 description 1
• GBZFILBGEYHYAE-UHFFFAOYSA-N 1,2,3,4-tetrahydronaphthalene-2-carbonyl chloride Chemical compound C1=CC=C2CC(C(=O)Cl)CCC2=C1 GBZFILBGEYHYAE-UHFFFAOYSA-N 0.000 description 1
• ZSVVFDHOQJEHJQ-UHFFFAOYSA-N 1-(3-phenylpropanoyl)piperidin-4-one Chemical compound C1CC(=O)CCN1C(=O)CCC1=CC=CC=C1 ZSVVFDHOQJEHJQ-UHFFFAOYSA-N 0.000 description 1
• PCOGRVFBIDICIW-UHFFFAOYSA-N 1-(4-chlorophenyl)sulfonyl-4-[[4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]methylidene]piperidine Chemical compound CN1CCN=C1C(C=C1)=CC=C1C=C1CCN(S(=O)(=O)C=2C=CC(Cl)=CC=2)CC1 PCOGRVFBIDICIW-UHFFFAOYSA-N 0.000 description 1
• RAKBJOQOOVBPHW-UHFFFAOYSA-N 1-(bromomethyl)-2-methoxy-4-methylbenzene Chemical compound COC1=CC(C)=CC=C1CBr RAKBJOQOOVBPHW-UHFFFAOYSA-N 0.000 description 1
• BSJADLYBLTWRDI-UHFFFAOYSA-N 1-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]-2-naphthalen-2-ylethanone Chemical compound C=1C=C2C=CC=CC2=CC=1CC(=O)N(CC1)CCC1=CC(C=C1)=CC=C1C1=NCCO1 BSJADLYBLTWRDI-UHFFFAOYSA-N 0.000 description 1
• CPDNBAYHTTWJRJ-UHFFFAOYSA-N 1-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]-3-phenylpropan-1-one Chemical compound C1CC(=CC=2C=CC(=CC=2)C=2OCCN=2)CCN1C(=O)CCC1=CC=CC=C1 CPDNBAYHTTWJRJ-UHFFFAOYSA-N 0.000 description 1
• IJKUPSCCJUTDHK-UHFFFAOYSA-N 1-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]-4-phenylbut-3-en-1-one Chemical compound C1CC(=CC=2C=CC(=CC=2)C=2OCCN=2)CCN1C(=O)CC=CC1=CC=CC=C1 IJKUPSCCJUTDHK-UHFFFAOYSA-N 0.000 description 1
• VUOAYKDIYGZVNX-UHFFFAOYSA-N 1-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]hexan-1-one Chemical compound C1CN(C(=O)CCCCC)CCC1=CC1=CC=C(C=2OCCN=2)C=C1 VUOAYKDIYGZVNX-UHFFFAOYSA-N 0.000 description 1
• OWNJHFWEWYTDEI-UHFFFAOYSA-N 1-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]octadecan-1-one Chemical compound C1CN(C(=O)CCCCCCCCCCCCCCCCC)CCC1=CC1=CC=C(C=2OCCN=2)C=C1 OWNJHFWEWYTDEI-UHFFFAOYSA-N 0.000 description 1
• PEWZYEDZYIBXPY-UHFFFAOYSA-N 1-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]pent-4-yn-1-one Chemical compound C1CN(C(CCC#C)=O)CCC1=CC1=CC=C(C=2OCCN=2)C=C1 PEWZYEDZYIBXPY-UHFFFAOYSA-N 0.000 description 1
• YLHUPYSUKYAIBW-UHFFFAOYSA-N 1-acetylpyrrolidin-2-one Chemical compound CC(=O)N1CCCC1=O YLHUPYSUKYAIBW-UHFFFAOYSA-N 0.000 description 1
• LXQMHOKEXZETKB-UHFFFAOYSA-N 1-amino-2-methylpropan-2-ol Chemical compound CC(C)(O)CN LXQMHOKEXZETKB-UHFFFAOYSA-N 0.000 description 1
• LEJMOTVCCRDZNE-UHFFFAOYSA-N 1-amino-3-(diethylamino)propan-2-ol Chemical compound CCN(CC)CC(O)CN LEJMOTVCCRDZNE-UHFFFAOYSA-N 0.000 description 1
• BBQQULRBTOMLTC-UHFFFAOYSA-N 1-benzylpiperidin-3-one Chemical compound C1C(=O)CCCN1CC1=CC=CC=C1 BBQQULRBTOMLTC-UHFFFAOYSA-N 0.000 description 1
• ARUHDSZAWXAVAY-UHFFFAOYSA-N 1-tritylazepan-4-one Chemical compound C1CC(=O)CCCN1C(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 ARUHDSZAWXAVAY-UHFFFAOYSA-N 0.000 description 1
• TTWLMWSWSQUXDB-UHFFFAOYSA-N 1-tritylpiperidin-4-one Chemical compound C1CC(=O)CCN1C(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 TTWLMWSWSQUXDB-UHFFFAOYSA-N 0.000 description 1
• 238000005160 1H NMR spectroscopy Methods 0.000 description 1
• DOTTUEYUTNVWMJ-KSTFQPQISA-N 2,2-dimethyl-3-[(3e,7e,11e,15e,19z)-3,7,12-trimethyl-16-prop-2-enylhenicosa-3,7,11,15,19-pentaenyl]oxirane Chemical compound C\C=C/CC\C(CC=C)=C/CC\C(C)=C\CC\C=C(/C)CC\C=C(/C)CCC1OC1(C)C DOTTUEYUTNVWMJ-KSTFQPQISA-N 0.000 description 1
• JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
• RLRUKKDFNWXXRT-UHFFFAOYSA-N 2,5-difluorobenzoyl chloride Chemical compound FC1=CC=C(F)C(C(Cl)=O)=C1 RLRUKKDFNWXXRT-UHFFFAOYSA-N 0.000 description 1
• ABIFHXWQHMSZHV-UHFFFAOYSA-N 2-(3,4-dichlorophenyl)-1-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]ethanone Chemical compound C1=C(Cl)C(Cl)=CC=C1CC(=O)N(CC1)CCC1=CC1=CC=C(C=2OCCN=2)C=C1 ABIFHXWQHMSZHV-UHFFFAOYSA-N 0.000 description 1
• CJJURHKDGQSBLE-UHFFFAOYSA-N 2-(3,4-dichlorophenyl)acetyl chloride Chemical compound ClC(=O)CC1=CC=C(Cl)C(Cl)=C1 CJJURHKDGQSBLE-UHFFFAOYSA-N 0.000 description 1
• UMQUIRYNOVNYPA-UHFFFAOYSA-N 2-(4-chlorophenyl)acetyl chloride Chemical compound ClC(=O)CC1=CC=C(Cl)C=C1 UMQUIRYNOVNYPA-UHFFFAOYSA-N 0.000 description 1
• MXIUWSYTQJLIKE-UHFFFAOYSA-N 2-(trifluoromethyl)benzoyl chloride Chemical compound FC(F)(F)C1=CC=CC=C1C(Cl)=O MXIUWSYTQJLIKE-UHFFFAOYSA-N 0.000 description 1
• HAZGPPFPMLSDFM-UHFFFAOYSA-N 2-[4-(pyrrolidin-3-ylidenemethyl)phenyl]-4,5-dihydro-1,3-oxazole Chemical compound C1NCCC1=CC1=CC=C(C=2OCCN=2)C=C1 HAZGPPFPMLSDFM-UHFFFAOYSA-N 0.000 description 1
• IWSZXYRQTKCIHA-UHFFFAOYSA-N 2-[4-[[1-(4-chlorophenyl)sulfonylpiperidin-4-yl]methyl]phenyl]-4,5-dihydro-1,3-oxazole Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)N1CCC(CC=2C=CC(=CC=2)C=2OCCN=2)CC1 IWSZXYRQTKCIHA-UHFFFAOYSA-N 0.000 description 1
• KJJPLEZQSCZCKE-UHFFFAOYSA-N 2-aminopropane-1,3-diol Chemical compound OCC(N)CO KJJPLEZQSCZCKE-UHFFFAOYSA-N 0.000 description 1
• ONIKNECPXCLUHT-UHFFFAOYSA-N 2-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1Cl ONIKNECPXCLUHT-UHFFFAOYSA-N 0.000 description 1
• QEJGMKHQXSZCOS-UHFFFAOYSA-N 2-naphthalen-2-ylacetyl chloride Chemical compound C1=CC=CC2=CC(CC(=O)Cl)=CC=C21 QEJGMKHQXSZCOS-UHFFFAOYSA-N 0.000 description 1
• KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
• VTXNOVCTHUBABW-UHFFFAOYSA-N 3,4-dichlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C(Cl)=C1 VTXNOVCTHUBABW-UHFFFAOYSA-N 0.000 description 1
• RPQWXGVZELKOEU-UHFFFAOYSA-N 3,4-difluorobenzoyl chloride Chemical compound FC1=CC=C(C(Cl)=O)C=C1F RPQWXGVZELKOEU-UHFFFAOYSA-N 0.000 description 1
• WAKMMQSMEDJRRI-UHFFFAOYSA-N 3,5-bis(trifluoromethyl)benzoyl chloride Chemical compound FC(F)(F)C1=CC(C(Cl)=O)=CC(C(F)(F)F)=C1 WAKMMQSMEDJRRI-UHFFFAOYSA-N 0.000 description 1
• QEAKAWUPYLOWOZ-UHFFFAOYSA-N 3-(4-chlorophenyl)-1-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]prop-2-en-1-one Chemical compound C1=CC(Cl)=CC=C1C=CC(=O)N(CC1)CCC1=CC1=CC=C(C=2OCCN=2)C=C1 QEAKAWUPYLOWOZ-UHFFFAOYSA-N 0.000 description 1
• ZFOVCSTVYYYRSU-UHFFFAOYSA-N 3-(4-chlorophenyl)prop-2-enoyl chloride Chemical compound ClC(=O)C=CC1=CC=C(Cl)C=C1 ZFOVCSTVYYYRSU-UHFFFAOYSA-N 0.000 description 1
• CVKOOKPNCVYHNY-UHFFFAOYSA-N 3-(bromomethyl)benzonitrile Chemical compound BrCC1=CC=CC(C#N)=C1 CVKOOKPNCVYHNY-UHFFFAOYSA-N 0.000 description 1
• RUJYJCANMOTJMO-UHFFFAOYSA-N 3-(trifluoromethyl)benzoyl chloride Chemical compound FC(F)(F)C1=CC=CC(C(Cl)=O)=C1 RUJYJCANMOTJMO-UHFFFAOYSA-N 0.000 description 1
• YFBBGBTUXAEVKO-UHFFFAOYSA-N 3-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]pyrrolidin-2-one Chemical compound O=C1NCCC1=CC1=CC=C(C=2OCCN=2)C=C1 YFBBGBTUXAEVKO-UHFFFAOYSA-N 0.000 description 1
• MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
• UMLFTCYAQPPZER-UHFFFAOYSA-N 4-(bromomethyl)benzonitrile Chemical compound BrCC1=CC=C(C#N)C=C1 UMLFTCYAQPPZER-UHFFFAOYSA-N 0.000 description 1
• XYSHFGZNSFLXIM-UHFFFAOYSA-N 4-(piperidin-3-ylidenemethyl)benzonitrile;hydrochloride Chemical compound Cl.C1=CC(C#N)=CC=C1C=C1CNCCC1 XYSHFGZNSFLXIM-UHFFFAOYSA-N 0.000 description 1
• OXZYBOLWRXENKT-UHFFFAOYSA-N 4-(trifluoromethyl)benzoyl chloride Chemical compound FC(F)(F)C1=CC=C(C(Cl)=O)C=C1 OXZYBOLWRXENKT-UHFFFAOYSA-N 0.000 description 1
• FKWHSEVXBBEGHY-UHFFFAOYSA-N 4-[(2-oxopyrrolidin-3-ylidene)methyl]benzonitrile Chemical compound O=C1NCCC1=CC1=CC=C(C#N)C=C1 FKWHSEVXBBEGHY-UHFFFAOYSA-N 0.000 description 1
• SYYBOGCJLLPBKD-UHFFFAOYSA-N 4-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methyl]piperidine-1-carbonyl]benzonitrile Chemical compound C(#N)C1=CC=C(C(=O)N2CCC(CC2)CC2=CC=C(C=C2)C=2OCCN=2)C=C1 SYYBOGCJLLPBKD-UHFFFAOYSA-N 0.000 description 1
• FUEOIPLPACLDON-UHFFFAOYSA-N 4-[[1-(4-chlorobenzoyl)piperidin-4-ylidene]methyl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C=C1CCN(C(=O)C=2C=CC(Cl)=CC=2)CC1 FUEOIPLPACLDON-UHFFFAOYSA-N 0.000 description 1
• CMVYOZWCMWODBP-UHFFFAOYSA-N 4-[[1-(4-chlorophenyl)sulfonylpiperidin-4-ylidene]methyl]benzonitrile Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)N(CC1)CCC1=CC1=CC=C(C#N)C=C1 CMVYOZWCMWODBP-UHFFFAOYSA-N 0.000 description 1
• DENKGPBHLYFNGK-UHFFFAOYSA-N 4-bromobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Br)C=C1 DENKGPBHLYFNGK-UHFFFAOYSA-N 0.000 description 1
• NECBSSKNQDXVKN-UHFFFAOYSA-N 4-chloro-3-methylbenzoyl chloride Chemical compound CC1=CC(C(Cl)=O)=CC=C1Cl NECBSSKNQDXVKN-UHFFFAOYSA-N 0.000 description 1
• ZLYBFBAHAQEEQQ-UHFFFAOYSA-N 4-chlorobenzenesulfonyl chloride Chemical compound ClC1=CC=C(S(Cl)(=O)=O)C=C1 ZLYBFBAHAQEEQQ-UHFFFAOYSA-N 0.000 description 1
• WZWIQYMTQZCSKI-UHFFFAOYSA-N 4-cyanobenzaldehyde Chemical compound O=CC1=CC=C(C#N)C=C1 WZWIQYMTQZCSKI-UHFFFAOYSA-N 0.000 description 1
• CQLBEAMZOMLJJY-UHFFFAOYSA-N 4-fluoronaphthalene-1-carbonyl chloride Chemical compound C1=CC=C2C(F)=CC=C(C(Cl)=O)C2=C1 CQLBEAMZOMLJJY-UHFFFAOYSA-N 0.000 description 1
• IPEIDGXNXFPGBG-UHFFFAOYSA-N 4-methylsulfonylbenzoyl chloride Chemical compound CS(=O)(=O)C1=CC=C(C(Cl)=O)C=C1 IPEIDGXNXFPGBG-UHFFFAOYSA-N 0.000 description 1
• SKDHHIUENRGTHK-UHFFFAOYSA-N 4-nitrobenzoyl chloride Chemical compound [O-][N+](=O)C1=CC=C(C(Cl)=O)C=C1 SKDHHIUENRGTHK-UHFFFAOYSA-N 0.000 description 1
• JPVUWCPKMYXOKW-UHFFFAOYSA-N 4-phenylbenzoyl chloride Chemical compound C1=CC(C(=O)Cl)=CC=C1C1=CC=CC=C1 JPVUWCPKMYXOKW-UHFFFAOYSA-N 0.000 description 1
• BMPDCQVRKDNUAP-UHFFFAOYSA-N 5-chlorothiophene-2-carbonyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)S1 BMPDCQVRKDNUAP-UHFFFAOYSA-N 0.000 description 1
• OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
• ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
• DJQOOSBJCLSSEY-UHFFFAOYSA-N Acipimox Chemical compound CC1=CN=C(C(O)=O)C=[N+]1[O-] DJQOOSBJCLSSEY-UHFFFAOYSA-N 0.000 description 1
• 201000004384 Alopecia Diseases 0.000 description 1
• 241000228245 Aspergillus niger Species 0.000 description 1
• 201000006474 Brain Ischemia Diseases 0.000 description 1
• 239000004215 Carbon black (E152) Substances 0.000 description 1
• 208000002177 Cataract Diseases 0.000 description 1
• 229920001268 Cholestyramine Polymers 0.000 description 1
• LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
• OXVGKRNCNGPOKY-UHFFFAOYSA-N Cl.C(C)OP(OCC)(=O)CC1=CC=CC=C1 Chemical compound Cl.C(C)OP(OCC)(=O)CC1=CC=CC=C1 OXVGKRNCNGPOKY-UHFFFAOYSA-N 0.000 description 1
• 241001207508 Cladosporium sp. Species 0.000 description 1
• ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
• 229920002911 Colestipol Polymers 0.000 description 1
• ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
• 201000004624 Dermatitis Diseases 0.000 description 1
• BDCFUHIWJODVNG-UHFFFAOYSA-N Desmosterol Natural products C1C=C2CC(O)C=CC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 BDCFUHIWJODVNG-UHFFFAOYSA-N 0.000 description 1
• 206010014476 Elevated cholesterol Diseases 0.000 description 1
• 241001125671 Eretmochelys imbricata Species 0.000 description 1
• DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
• JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
• 108010022535 Farnesyl-Diphosphate Farnesyltransferase Proteins 0.000 description 1
• 206010017533 Fungal infection Diseases 0.000 description 1
• HEMJJKBWTPKOJG-UHFFFAOYSA-N Gemfibrozil Chemical compound CC1=CC=C(C)C(OCCCC(C)(C)C(O)=O)=C1 HEMJJKBWTPKOJG-UHFFFAOYSA-N 0.000 description 1
• 241000250507 Gigaspora candida Species 0.000 description 1
• 244000068988 Glycine max Species 0.000 description 1
• 235000010469 Glycine max Nutrition 0.000 description 1
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
• 101000839025 Homo sapiens Hydroxymethylglutaryl-CoA synthase, cytoplasmic Proteins 0.000 description 1
• 108010000775 Hydroxymethylglutaryl-CoA synthase Proteins 0.000 description 1
• 102100028888 Hydroxymethylglutaryl-CoA synthase, cytoplasmic Human genes 0.000 description 1
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
• 241000699673 Mesocricetus auratus Species 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 1
• 125000003047 N-acetyl group Chemical group 0.000 description 1
• 229930193140 Neomycin Natural products 0.000 description 1
• 206010067482 No adverse event Diseases 0.000 description 1
• 208000031481 Pathologic Constriction Diseases 0.000 description 1
• 241000228168 Penicillium sp. Species 0.000 description 1
• 239000007868 Raney catalyst Substances 0.000 description 1
• 229910000564 Raney nickel Inorganic materials 0.000 description 1
• NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
• 241000700157 Rattus norvegicus Species 0.000 description 1
• 229940123934 Reductase inhibitor Drugs 0.000 description 1
• 206010040914 Skin reaction Diseases 0.000 description 1
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
• 235000019764 Soybean Meal Nutrition 0.000 description 1
• 241001045770 Trichophyton mentagrophytes Species 0.000 description 1
• QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
• 240000008042 Zea mays Species 0.000 description 1
• 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
• 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
• CQFUJYRZIACHNS-UHFFFAOYSA-N [3,5-bis(trifluoromethyl)phenyl]-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]methanone Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C(=O)N2CCC(CC2)=CC=2C=CC(=CC=2)C=2OCCN=2)=C1 CQFUJYRZIACHNS-UHFFFAOYSA-N 0.000 description 1
• NXKRPBASXOOEDP-UHFFFAOYSA-N [4-[[2-bromo-4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]-(4-chlorophenyl)methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)N(CC1)CCC1=CC1=CC=C(C=2OCCN=2)C=C1Br NXKRPBASXOOEDP-UHFFFAOYSA-N 0.000 description 1
• KPGLZPVYEBXPGC-UHFFFAOYSA-N [4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methyl]piperidin-1-yl]-(4-methylphenyl)methanone Chemical compound C1=CC(C)=CC=C1C(=O)N1CCC(CC=2C=CC(=CC=2)C=2OCCN=2)CC1 KPGLZPVYEBXPGC-UHFFFAOYSA-N 0.000 description 1
• JRSLFDCOWGXVCC-UHFFFAOYSA-N [4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methyl]piperidin-1-yl]-(4-phenylphenyl)methanone Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1C(=O)N(CC1)CCC1CC(C=C1)=CC=C1C1=NCCO1 JRSLFDCOWGXVCC-UHFFFAOYSA-N 0.000 description 1
• OWHFSMAEVRLJQZ-UHFFFAOYSA-N [4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methyl]piperidin-1-yl]-naphthalen-1-ylmethanone Chemical compound C=1C=CC2=CC=CC=C2C=1C(=O)N(CC1)CCC1CC(C=C1)=CC=C1C1=NCCO1 OWHFSMAEVRLJQZ-UHFFFAOYSA-N 0.000 description 1
• KNTCWBHQXNCCOO-UHFFFAOYSA-N [4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methyl]piperidin-1-yl]-naphthalen-2-ylmethanone Chemical compound C=1C=C2C=CC=CC2=CC=1C(=O)N(CC1)CCC1CC(C=C1)=CC=C1C1=NCCO1 KNTCWBHQXNCCOO-UHFFFAOYSA-N 0.000 description 1
• ZPYIGRQPZFYYPT-UHFFFAOYSA-N [4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methyl]piperidin-1-yl]-phenylmethanone Chemical compound C=1C=CC=CC=1C(=O)N(CC1)CCC1CC(C=C1)=CC=C1C1=NCCO1 ZPYIGRQPZFYYPT-UHFFFAOYSA-N 0.000 description 1
• LHDMHTFSHBEGSZ-UHFFFAOYSA-N [4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methyl]piperidin-1-yl]-pyridin-4-ylmethanone Chemical compound C=1C=NC=CC=1C(=O)N(CC1)CCC1CC(C=C1)=CC=C1C1=NCCO1 LHDMHTFSHBEGSZ-UHFFFAOYSA-N 0.000 description 1
• PEVOXMAYCOSPBW-UHFFFAOYSA-N [4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]-(1,2,3,4-tetrahydronaphthalen-2-yl)methanone Chemical compound C1CC2=CC=CC=C2CC1C(=O)N(CC1)CCC1=CC(C=C1)=CC=C1C1=NCCO1 PEVOXMAYCOSPBW-UHFFFAOYSA-N 0.000 description 1
• ZMTRVSSWNKUESL-UHFFFAOYSA-N [4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]-(4-fluoronaphthalen-1-yl)methanone Chemical compound C12=CC=CC=C2C(F)=CC=C1C(=O)N(CC1)CCC1=CC(C=C1)=CC=C1C1=NCCO1 ZMTRVSSWNKUESL-UHFFFAOYSA-N 0.000 description 1
• LAPWBHKXJALOOA-UHFFFAOYSA-N [4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]-(4-methylphenyl)methanone Chemical compound C1=CC(C)=CC=C1C(=O)N(CC1)CCC1=CC1=CC=C(C=2OCCN=2)C=C1 LAPWBHKXJALOOA-UHFFFAOYSA-N 0.000 description 1
• SCHVDNCUQCJZIO-UHFFFAOYSA-N [4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]-(4-methylsulfonylphenyl)methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C(=O)N(CC1)CCC1=CC1=CC=C(C=2OCCN=2)C=C1 SCHVDNCUQCJZIO-UHFFFAOYSA-N 0.000 description 1
• ACSLQLLUYLBGGK-UHFFFAOYSA-N [4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]-[2-(trifluoromethyl)phenyl]methanone Chemical compound FC(F)(F)C1=CC=CC=C1C(=O)N(CC1)CCC1=CC1=CC=C(C=2OCCN=2)C=C1 ACSLQLLUYLBGGK-UHFFFAOYSA-N 0.000 description 1
• JWCHPIWKRPJAJE-UHFFFAOYSA-N [4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]-[3-(trifluoromethyl)phenyl]methanone Chemical compound FC(F)(F)C1=CC=CC(C(=O)N2CCC(CC2)=CC=2C=CC(=CC=2)C=2OCCN=2)=C1 JWCHPIWKRPJAJE-UHFFFAOYSA-N 0.000 description 1
• UXSWKSZXYYGMBX-UHFFFAOYSA-N [4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]-naphthalen-2-ylmethanone Chemical compound C=1C=C2C=CC=CC2=CC=1C(=O)N(CC1)CCC1=CC(C=C1)=CC=C1C1=NCCO1 UXSWKSZXYYGMBX-UHFFFAOYSA-N 0.000 description 1
• FLMCIOCLAVAMOL-HHHXNRCGSA-N [4-[[4-[(4r)-4-benzyl-4,5-dihydro-1,3-oxazol-2-yl]phenyl]methylidene]piperidin-1-yl]-(4-chlorophenyl)methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)N(CC1)CCC1=CC1=CC=C(C=2OC[C@@H](CC=3C=CC=CC=3)N=2)C=C1 FLMCIOCLAVAMOL-HHHXNRCGSA-N 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• 238000005903 acid hydrolysis reaction Methods 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 229960003526 acipimox Drugs 0.000 description 1
• 239000000443 aerosol Substances 0.000 description 1
• 150000001299 aldehydes Chemical class 0.000 description 1
• 239000003513 alkali Substances 0.000 description 1
• 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
• 239000002168 alkylating agent Substances 0.000 description 1
• 229940100198 alkylating agent Drugs 0.000 description 1
• 231100000360 alopecia Toxicity 0.000 description 1
• 125000003368 amide group Chemical group 0.000 description 1
• CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
• MXMOTZIXVICDSD-UHFFFAOYSA-N anisoyl chloride Chemical compound COC1=CC=C(C(Cl)=O)C=C1 MXMOTZIXVICDSD-UHFFFAOYSA-N 0.000 description 1
• 239000005557 antagonist Substances 0.000 description 1
• 230000000843 anti-fungal effect Effects 0.000 description 1
• 230000001857 anti-mycotic effect Effects 0.000 description 1
• 230000001028 anti-proliverative effect Effects 0.000 description 1
• 239000003524 antilipemic agent Substances 0.000 description 1
• GMHPWGYTSXHHPI-UHFFFAOYSA-N azepan-4-one Chemical compound O=C1CCCNCC1 GMHPWGYTSXHHPI-UHFFFAOYSA-N 0.000 description 1
• 210000000270 basal cell Anatomy 0.000 description 1
• 235000013871 bee wax Nutrition 0.000 description 1
• 239000012166 beeswax Substances 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
• LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
• NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
• 229960000516 bezafibrate Drugs 0.000 description 1
• IIBYAHWJQTYFKB-UHFFFAOYSA-N bezafibrate Chemical compound C1=CC(OC(C)(C)C(O)=O)=CC=C1CCNC(=O)C1=CC=C(Cl)C=C1 IIBYAHWJQTYFKB-UHFFFAOYSA-N 0.000 description 1
• 229920000080 bile acid sequestrant Polymers 0.000 description 1
• 230000008687 biosynthesis inhibition Effects 0.000 description 1
• 125000006267 biphenyl group Chemical group 0.000 description 1
• 210000004369 blood Anatomy 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
• 229940095731 candida albicans Drugs 0.000 description 1
• 229910052799 carbon Inorganic materials 0.000 description 1
• 229910002091 carbon monoxide Inorganic materials 0.000 description 1
• 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
• 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
• 238000004113 cell culture Methods 0.000 description 1
• 230000022131 cell cycle Effects 0.000 description 1
• 230000032823 cell division Effects 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 210000003850 cellular structure Anatomy 0.000 description 1
• 206010008118 cerebral infarction Diseases 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• JESCPVSKEGXYSC-UHFFFAOYSA-N chlorobenzene;sulfurochloridic acid Chemical compound OS(Cl)(=O)=O.ClC1=CC=CC=C1 JESCPVSKEGXYSC-UHFFFAOYSA-N 0.000 description 1
• 238000004587 chromatography analysis Methods 0.000 description 1
• 208000024980 claudication Diseases 0.000 description 1
• 238000003776 cleavage reaction Methods 0.000 description 1
• 229960001214 clofibrate Drugs 0.000 description 1
• KNHUKKLJHYUCFP-UHFFFAOYSA-N clofibrate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 KNHUKKLJHYUCFP-UHFFFAOYSA-N 0.000 description 1
• 239000011248 coating agent Substances 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
• 235000017471 coenzyme Q10 Nutrition 0.000 description 1
• GMRWGQCZJGVHKL-UHFFFAOYSA-N colestipol Chemical compound ClCC1CO1.NCCNCCNCCNCCN GMRWGQCZJGVHKL-UHFFFAOYSA-N 0.000 description 1
• 229960002604 colestipol Drugs 0.000 description 1
• 230000001332 colony forming effect Effects 0.000 description 1
• 235000005822 corn Nutrition 0.000 description 1
• 238000007887 coronary angioplasty Methods 0.000 description 1
• 238000002425 crystallisation Methods 0.000 description 1
• 230000008025 crystallization Effects 0.000 description 1
• RVOJTCZRIKWHDX-UHFFFAOYSA-N cyclohexanecarbonyl chloride Chemical compound ClC(=O)C1CCCCC1 RVOJTCZRIKWHDX-UHFFFAOYSA-N 0.000 description 1
• ZOOSILUVXHVRJE-UHFFFAOYSA-N cyclopropanecarbonyl chloride Chemical compound ClC(=O)C1CC1 ZOOSILUVXHVRJE-UHFFFAOYSA-N 0.000 description 1
• HCBDPGVEZOZDJN-UHFFFAOYSA-N cyclopropyl-[4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methylidene]piperidin-1-yl]methanone Chemical compound C1CC(=CC=2C=CC(=CC=2)C=2OCCN=2)CCN1C(=O)C1CC1 HCBDPGVEZOZDJN-UHFFFAOYSA-N 0.000 description 1
• 125000004855 decalinyl group Chemical group C1(CCCC2CCCCC12)* 0.000 description 1
• 230000001419 dependent effect Effects 0.000 description 1
• 210000004207 dermis Anatomy 0.000 description 1
• AVSXSVCZWQODGV-DPAQBDIFSA-N desmosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@@H](CCC=C(C)C)C)[C@@]1(C)CC2 AVSXSVCZWQODGV-DPAQBDIFSA-N 0.000 description 1
• WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 1
• 230000004069 differentiation Effects 0.000 description 1
• SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
• IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
• 229940043279 diisopropylamine Drugs 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 239000012895 dilution Substances 0.000 description 1
• 238000004821 distillation Methods 0.000 description 1
• 210000001339 epidermal cell Anatomy 0.000 description 1
• 210000005175 epidermal keratinocyte Anatomy 0.000 description 1
• DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
• 125000004494 ethyl ester group Chemical group 0.000 description 1
• 230000029142 excretion Effects 0.000 description 1
• 238000002474 experimental method Methods 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 238000011049 filling Methods 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 244000053095 fungal pathogen Species 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• 210000001035 gastrointestinal tract Anatomy 0.000 description 1
• 239000000499 gel Substances 0.000 description 1
• 239000007903 gelatin capsule Substances 0.000 description 1
• 229960003627 gemfibrozil Drugs 0.000 description 1
• 239000012362 glacial acetic acid Substances 0.000 description 1
• 210000000224 granular leucocyte Anatomy 0.000 description 1
• 230000009548 growth disturbance Effects 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• 229940093915 gynecological organic acid Drugs 0.000 description 1
• 150000004820 halides Chemical class 0.000 description 1
• 238000010438 heat treatment Methods 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
• YWGHUJQYGPDNKT-UHFFFAOYSA-N hexanoyl chloride Chemical compound CCCCCC(Cl)=O YWGHUJQYGPDNKT-UHFFFAOYSA-N 0.000 description 1
• 238000004128 high performance liquid chromatography Methods 0.000 description 1
• 229930195733 hydrocarbon Natural products 0.000 description 1
• 150000002430 hydrocarbons Chemical class 0.000 description 1
• 150000003840 hydrochlorides Chemical class 0.000 description 1
• 150000002431 hydrogen Chemical class 0.000 description 1
• 230000001329 hyperkeratotic effect Effects 0.000 description 1
• 208000020346 hyperlipoproteinemia Diseases 0.000 description 1
• 208000006575 hypertriglyceridemia Diseases 0.000 description 1
• 206010021198 ichthyosis Diseases 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• PQNFLJBBNBOBRQ-UHFFFAOYSA-N indane Chemical class C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 description 1
• 208000015181 infectious disease Diseases 0.000 description 1
• 230000008595 infiltration Effects 0.000 description 1
• 238000001764 infiltration Methods 0.000 description 1
• 210000004969 inflammatory cell Anatomy 0.000 description 1
• 239000002054 inoculum Substances 0.000 description 1
• 150000007529 inorganic bases Chemical class 0.000 description 1
• 229910052500 inorganic mineral Inorganic materials 0.000 description 1
• 239000013067 intermediate product Substances 0.000 description 1
• 208000021156 intermittent vascular claudication Diseases 0.000 description 1
• INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
• 210000002429 large intestine Anatomy 0.000 description 1
• 230000003902 lesion Effects 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 239000006210 lotion Substances 0.000 description 1
• 235000013372 meat Nutrition 0.000 description 1
• 230000010534 mechanism of action Effects 0.000 description 1
• 238000002483 medication Methods 0.000 description 1
• CFJQBNFFHMBNKQ-UHFFFAOYSA-N methyl 3-bromo-4-(bromomethyl)benzoate Chemical compound COC(=O)C1=CC=C(CBr)C(Br)=C1 CFJQBNFFHMBNKQ-UHFFFAOYSA-N 0.000 description 1
• MASRAGFWFYHMFI-UHFFFAOYSA-N methyl 3-bromo-4-methylbenzoate Chemical compound COC(=O)C1=CC=C(C)C(Br)=C1 MASRAGFWFYHMFI-UHFFFAOYSA-N 0.000 description 1
• RAFFOVQBMRBRCS-UHFFFAOYSA-N methyl 3-fluoro-4-methylbenzoate Chemical compound COC(=O)C1=CC=C(C)C(F)=C1 RAFFOVQBMRBRCS-UHFFFAOYSA-N 0.000 description 1
• LLEXCSBUSVRBCA-UHFFFAOYSA-N methyl 3-methoxy-4-methylbenzoate Chemical compound COC(=O)C1=CC=C(C)C(OC)=C1 LLEXCSBUSVRBCA-UHFFFAOYSA-N 0.000 description 1
• MABHQNNTZZMWCU-UHFFFAOYSA-N methyl 4-(bromomethyl)-2-methylbenzoate Chemical compound COC(=O)C1=CC=C(CBr)C=C1C MABHQNNTZZMWCU-UHFFFAOYSA-N 0.000 description 1
• OJBQAHZJVDWSFD-UHFFFAOYSA-N methyl 4-(bromomethyl)-3-fluorobenzoate Chemical compound COC(=O)C1=CC=C(CBr)C(F)=C1 OJBQAHZJVDWSFD-UHFFFAOYSA-N 0.000 description 1
• 229920000609 methyl cellulose Polymers 0.000 description 1
• 239000001923 methylcellulose Substances 0.000 description 1
• 235000013336 milk Nutrition 0.000 description 1
• 239000008267 milk Substances 0.000 description 1
• 210000004080 milk Anatomy 0.000 description 1
• 239000011707 mineral Substances 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 229960004927 neomycin Drugs 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 229960003512 nicotinic acid Drugs 0.000 description 1
• 235000001968 nicotinic acid Nutrition 0.000 description 1
• 239000011664 nicotinic acid Substances 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 235000016709 nutrition Nutrition 0.000 description 1
• 230000035764 nutrition Effects 0.000 description 1
• WTBAHSZERDXKKZ-UHFFFAOYSA-N octadecanoyl chloride Chemical compound CCCCCCCCCCCCCCCCCC(Cl)=O WTBAHSZERDXKKZ-UHFFFAOYSA-N 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 150000002918 oxazolines Chemical class 0.000 description 1
• 150000002924 oxiranes Chemical class 0.000 description 1
• TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
• MLBYLEUJXUBIJJ-UHFFFAOYSA-N pent-4-ynoic acid Chemical compound OC(=O)CCC#C MLBYLEUJXUBIJJ-UHFFFAOYSA-N 0.000 description 1
• MYHOHFDYWMPGJY-UHFFFAOYSA-N pentafluorobenzoyl chloride Chemical compound FC1=C(F)C(F)=C(C(Cl)=O)C(F)=C1F MYHOHFDYWMPGJY-UHFFFAOYSA-N 0.000 description 1
• 239000000825 pharmaceutical preparation Substances 0.000 description 1
• AQSJGOWTSHOLKH-UHFFFAOYSA-N phosphite(3-) Chemical class [O-]P([O-])[O-] AQSJGOWTSHOLKH-UHFFFAOYSA-N 0.000 description 1
• UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
• 229910000027 potassium carbonate Inorganic materials 0.000 description 1
• FYPMFJGVHOHGLL-UHFFFAOYSA-N probucol Chemical compound C=1C(C(C)(C)C)=C(O)C(C(C)(C)C)=CC=1SC(C)(C)SC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 FYPMFJGVHOHGLL-UHFFFAOYSA-N 0.000 description 1
• 229960003912 probucol Drugs 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• 238000011321 prophylaxis Methods 0.000 description 1
• 230000001185 psoriatic effect Effects 0.000 description 1
• RVQZKNOMKUSGCI-UHFFFAOYSA-N pyridine-4-carbonyl chloride Chemical compound ClC(=O)C1=CC=NC=C1 RVQZKNOMKUSGCI-UHFFFAOYSA-N 0.000 description 1
• 238000001953 recrystallisation Methods 0.000 description 1
• NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 229910052703 rhodium Inorganic materials 0.000 description 1
• 239000010948 rhodium Substances 0.000 description 1
• MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
• 230000007017 scission Effects 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 230000035939 shock Effects 0.000 description 1
• 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
• 238000006884 silylation reaction Methods 0.000 description 1
• KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
• 229950005143 sitosterol Drugs 0.000 description 1
• 235000015500 sitosterol Nutrition 0.000 description 1
• NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
• 210000004927 skin cell Anatomy 0.000 description 1
• 231100000430 skin reaction Toxicity 0.000 description 1
• 230000035483 skin reaction Effects 0.000 description 1
• 239000007787 solid Substances 0.000 description 1
• 238000007711 solidification Methods 0.000 description 1
• 230000008023 solidification Effects 0.000 description 1
• 239000004455 soybean meal Substances 0.000 description 1
• 235000012424 soybean oil Nutrition 0.000 description 1
• 239000003549 soybean oil Substances 0.000 description 1
• 238000001228 spectrum Methods 0.000 description 1
• 239000004059 squalene synthase inhibitor Substances 0.000 description 1
• 208000037804 stenosis Diseases 0.000 description 1
• 230000036262 stenosis Effects 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 238000011477 surgical intervention Methods 0.000 description 1
• 239000003826 tablet Substances 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 1
• HPNGBFRWLFYGTL-UHFFFAOYSA-N tert-butyl 4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1CC1=CC=C(C=2OCCN=2)C=C1 HPNGBFRWLFYGTL-UHFFFAOYSA-N 0.000 description 1
• ROUYFJUVMYHXFJ-UHFFFAOYSA-N tert-butyl 4-oxopiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(=O)CC1 ROUYFJUVMYHXFJ-UHFFFAOYSA-N 0.000 description 1
• 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 230000001225 therapeutic effect Effects 0.000 description 1
• 238000011200 topical administration Methods 0.000 description 1
• 239000012049 topical pharmaceutical composition Substances 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• PSCXFXNEYIHJST-UHFFFAOYSA-N trans-styrilacetic acid Natural products OC(=O)CC=CC1=CC=CC=C1 PSCXFXNEYIHJST-UHFFFAOYSA-N 0.000 description 1
• 150000003852 triazoles Chemical class 0.000 description 1
• 239000005051 trimethylchlorosilane Substances 0.000 description 1
• SYHDSBBKRLVLFF-UHFFFAOYSA-N triparanol Chemical compound C1=CC(OCCN(CC)CC)=CC=C1C(O)(C=1C=CC(C)=CC=1)CC1=CC=C(Cl)C=C1 SYHDSBBKRLVLFF-UHFFFAOYSA-N 0.000 description 1
• 229950005498 triparanol Drugs 0.000 description 1
• 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
• 230000004614 tumor growth Effects 0.000 description 1
• 230000007306 turnover Effects 0.000 description 1
• 229940035936 ubiquinone Drugs 0.000 description 1
• 238000010792 warming Methods 0.000 description 1
• 238000005406 washing Methods 0.000 description 1
• DFKDOZMCHOGOBR-NCSQYGPNSA-N zaragozic acid A Chemical compound C([C@@H](C)[C@H](OC(C)=O)C(=C)CC[C@]12[C@H](O)[C@H]([C@](O2)(C(O)=O)[C@@](O)([C@H](O1)C(O)=O)C(O)=O)OC(=O)/C=C/[C@@H](C)C[C@@H](C)CC)C1=CC=CC=C1 DFKDOZMCHOGOBR-NCSQYGPNSA-N 0.000 description 1
• DFKDOZMCHOGOBR-UHFFFAOYSA-N zaragozic acid A Natural products O1C(C(O)(C(O2)C(O)=O)C(O)=O)(C(O)=O)C(OC(=O)C=CC(C)CC(C)CC)C(O)C21CCC(=C)C(OC(C)=O)C(C)CC1=CC=CC=C1 DFKDOZMCHOGOBR-UHFFFAOYSA-N 0.000 description 1